Clinical Trial Update: A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities [Phase 2]

View source ↗

Summary

Phase II clinical trial of SKB571 as monotherapy for locally advanced or metastatic non-small cell lung cancer with MET abnormalities; the study status is NOT_Y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SKB571

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Non-small Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING